TOOLGEN INCORPORATED

Highlights ToolGen Incorporated

Equities

A199800

KR7199800004

End-of-day quote Korea S.E. Other stock markets 23:00:00 09/05/2024 BST			5-day change	1st Jan Change
64,400 ^KRW	+0.78%		-3.01%	-8.26%

2023	ToolGen Incorporated announced that it has received KRW 33 billion in funding	CI
2023	ToolGen Incorporated announced that it expects to receive KRW 33 billion in funding	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Toolgen Leads Development of Numerous Cutting-Edge Genome Editing Techniques	18/04/23	CI
ToolGen Incorporated Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23	CI
MCureX Therapeutics, Inc. Signs Contract for Joint Research with Toolgen, Inc	15/06/22	CI
ToolGen Incorporated has completed an IPO in the amount of KRW 70 billion.	06/12/21	CI
ToolGen Incorporated has filed an IPO.	14/09/21	CI
Genexine, Inc. cancelled the acquisition of ToolGen Incorporated.	19/08/19	CI
Genexine, Inc. agreed to acquire ToolGen Incorporated for approximately KRW 350 billion.	18/06/19	CI
ToolGen, Inc., Demonstrates CRISPR/Cas9 Gene Editing Improves Anti-Tumor Activity of Human Car-T Cells	17/05/18	CI
Monsanto Company and ToolGen, Inc. Announce Global Licensing Agreement on CRISPR Platform, Underscore the Benefits of Innovation for Farmers	18/08/17	CI
ToolGen, Inc. Highlights Study Results Demonstrating Utility of AAV-Compatible Cas9 System in vivo Genome Editing	22/02/17	CI
Jong-Moon Kim acquired an additional unknown stake in ToolGen Incorporated from Seong-Hak Choi for KRW 2.7 billion.	11/02/16	CI
ToolGen, Inc. Signs License Agreement with Thermo Fisher Scientific	11/03/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer